FDA Inspection
F. Hoffmann-La Roche AGF. Hoffmann-La Roche AG – FDA Inspection, Jul 27, 2022
Record Details
This FDA Inspection record concerns F. Hoffmann-La Roche AG, with an inspection on July 27, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- F. Hoffmann-La Roche AG
- Inspection Date
- July 27, 2022
- Product Type
- Drugs
View Company Profile
ID · 32220fee-b660-429c-aa6e-0d06f239e486
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1180665
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of F. Hoffmann-La Roche AG
9| Date | Classification | Office | Project area |
|---|---|---|---|
| November 4, 2024 | Not classified | Office of Inspections and Investigations | |
| February 16, 2024 | Not classified | Office of Inspections and Investigations | |
| January 25, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 24, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for F. Hoffmann-La Roche AG
- FDA Inspection 1263730 - 2024-11-04
- FDA Inspection 1234887 - 2024-02-16
- FDA Inspection 1228527 - 2024-01-25
- FDA Inspection 1055453 - 2018-04-24
- FDA Inspection 990180 - 2016-09-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.